Dana Investment Advisors, Inc. Blueprint Medicines Corp Transaction History

Dana Investment Advisors, Inc.

$2.96 Billion
Q2 2025

A detailed history of Dana Investment Advisors, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 16,031 shares of BPMC stock, worth $2.08 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

16,031

Previous 37,551 57.31%

Holding current value

$2.08 Million

Previous $3.32 Million 38.19%

% of portfolio

0.07%

Previous 0.12%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$79.22 - $128.4 $1.7 Million - $2.76 Million	-21,520 Reduced 57.31%	16,031 $2.05 Million
Q1 2025 May 15, 2025	SELL	$86.69 - $115.63 $132,028 - $176,104	-1,523 Reduced 3.9%	37,551 $3.32 Million
Q4 2024 Feb 06, 2025	BUY	$82.48 - $101.39 $188,219 - $231,371	2,282 Added 6.2%	39,074 $3.41 Million
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $1.85 Million - $2.66 Million	22,048 Added 149.54%	36,792 $3.4 Million
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $94,890 - $121,180	1,114 Added 8.17%	14,744 $1.59 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $79,974 - $109,070	1,093 Added 8.72%	13,630 $1.29 Million
Q4 2023 Feb 07, 2024	SELL	$43.96 - $92.84 $231,801 - $489,545	-5,273 Reduced 29.61%	12,537 $1.16 Million
Q3 2023 Nov 15, 2023	SELL	$46.9 - $66.0 $88,359 - $124,344	-1,884 Reduced 9.57%	17,810 $894,000
Q2 2023 Aug 15, 2023	SELL	$42.2 - $66.37 $26,881 - $42,277	-637 Reduced 3.13%	19,694 $1.24 Million
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $44,007 - $57,950	-1,159 Reduced 5.39%	20,331 $914,000
Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $363,216 - $588,082	8,846 Added 69.96%	21,490 $941,000
Q3 2022 Nov 15, 2022	SELL	$49.93 - $77.7 $2,047 - $3,185	-41 Reduced 0.32%	12,644 $833,000
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $13,976 - $21,676	309 Added 2.5%	12,685 $641,000
Q1 2022 May 12, 2022	BUY	$54.1 - $110.08 $4,598 - $9,356	85 Added 0.69%	12,376 $791,000
Q4 2021 Feb 09, 2022	SELL	$94.25 - $115.99 $657,488 - $809,146	-6,976 Reduced 36.21%	12,291 $1.32 Million
Q3 2021 Nov 12, 2021	SELL	$80.98 - $109.47 $210,628 - $284,731	-2,601 Reduced 11.89%	19,267 $1.98 Million
Q2 2021 Aug 10, 2021	BUY	$82.78 - $101.0 $272,511 - $332,492	3,292 Added 17.72%	21,868 $1.92 Million
Q1 2021 May 13, 2021	BUY	$90.71 - $108.28 $329,277 - $393,056	3,630 Added 24.29%	18,576 $1.81 Million
Q4 2020 Feb 11, 2021	SELL	$92.08 - $124.48 $340,603 - $460,451	-3,699 Reduced 19.84%	14,946 $1.68 Million
Q3 2020 Nov 10, 2020	SELL	$66.45 - $92.7 $69,573 - $97,056	-1,047 Reduced 5.32%	18,645 $1.73 Million
Q2 2020 Aug 11, 2020	BUY	$57.09 - $79.27 $1.12 Million - $1.56 Million	19,692 New	19,692 $1.54 Million

Others Institutions Holding BPMC

# of Institutions

398

Shares Held

67.3M

Call Options Held

973K

Put Options Held

1.54M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.73B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account

Dana Investment Advisors, Inc. Blueprint Medicines Corp Transaction History